Schedule 13D ownership disclosure

RENEO PHARMACEUTICALS INC

Security class unavailable · CUSIP: 75974E103

Event date: 2023-11-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9960%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-23-016861
Form type
SC 13D
Filer
OnKure Therapeutics, Inc.
CIK
CIK 1637715
Filed
Dec 26, 2023
Reporting period
Nov 14, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub